The 5mg Mounjaro pen: deciding whether you're at the right point to use it

Why 5mg is a step-up, not a starting point

The decision your prescriber is weighing when you reach the end of your first pen is straightforward in principle: has your body tolerated 2.5mg well enough to move forward? In practice it requires a proper look at your experience, nausea frequency, any persistent GI upset, how your appetite has shifted, whether you had to delay any doses. The 2.5mg starter pen is calibrated for adjustment, not results. Its job is to introduce tirzepatide's dual GIP and GLP-1 receptor activity to your system gradually so the therapeutic doses that follow are better tolerated.

At 5mg, appetite suppression and the slowing of gastric emptying become more pronounced for most people, and you can read about what to expect from this stage on the Mounjaro 5mg pen page. You are moving into territory where the medicine begins to work in a clinically meaningful way. That is the point. The SURMOUNT-1 trial, published in the New England Journal of Medicine, tracked participants through the full titration sequence to the highest tolerated dose, and the weight-reduction outcomes that made headlines were achieved at the maintenance end of the range, not here. Reaching 5mg is progress toward that, not the destination.

If your tolerability at 2.5mg was difficult (persistent vomiting, severe nausea lasting beyond two weeks) your prescriber may decide to stay at the lower dose for longer before moving up. That is not a setback. It is the licensed approach working as intended.

What the dose increase actually feels like

Most people notice that GI symptoms pick up again when they move to the 5mg pen. Nausea, some loose stools, or a feeling of fullness that makes finishing meals difficult are all reported commonly, they mirror what many people experienced in the first week or two at 2.5mg, and they tend to follow the same pattern of settling down within a fortnight. The questions our team hears most often at this stage involve people wondering whether the symptoms mean something is wrong. Usually they do not; they mean the dose is active.

That said, there are symptoms that warrant more than patience. Severe, persistent stomach pain that radiates toward the back (with or without vomiting) should be assessed urgently, because acute pancreatitis is a known but infrequent side effect of GLP-1 class medicines flagged in MHRA guidance. Staying well hydrated matters more during any period of GI upset; if you cannot keep fluids down for an extended period, contact a healthcare professional. You can also report any suspected side effect through the Yellow Card scheme, which the MHRA runs for exactly this purpose.

Injection technique stays consistent whatever pen you are using: abdomen, outer thigh or upper arm, rotating the site each week. The pen itself is the same KwikPen format as the Mounjaro quick pen at 2.5mg, pre-filled with four doses.

How long most people spend at 5mg before moving on

The licensed schedule calls for a minimum of four weeks at each strength before any increase, and your prescriber will assess your response before approving the next pen. Some people stay at 5mg for longer than four weeks if further tolerability is needed. Others find it well-tolerated and move toward the higher doses relatively smoothly. The 10mg pen is typically what follows 5mg on the standard titration path, though the steps between are at your prescriber's discretion based on your clinical picture.

It is worth reading the Patient Information Leaflet that comes with your pen; it covers storage requirements (refrigerated at 2–8°C), what to do if a dose is missed, and the full list of side effects. Your prescriber and our aftercare team can answer clinical questions specific to your situation, no formulaic chatbot, a real person. The NHS tirzepatide page is also a reliable plain-English reference for what to expect at each stage.

Where cost fits into this decision

If you are thinking about whether to continue through the titration schedule from a cost perspective, it helps to understand how the pricing of private treatment works. Each pen covers four weeks, so the monthly cost rises at higher doses as the list price of those pens is higher. A detailed breakdown of what to expect is on the Mounjaro prices page, where you can also read about what is included in the cost at nume. Consultation, prescription, next-working-day DPD delivery and 7-day aftercare are all part of one transparent price, with no subscription locking you in.

That said, the financial question is secondary to a clinical one: if 5mg is working and you are tolerating it, the decision about whether to titrate further should be driven by your progress and your prescriber's assessment, not by a desire to stay at a cheaper pen. Spending months at a sub-therapeutic dose to save money is not a trade-off we would recommend, and neither would your prescriber. Each repeat order at nume is clinically reviewed before it is dispensed; that review is the moment to have these conversations. If you'd like to explore your options, you can speak to our prescribers through a free consultation.